"Lung Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LUNG.
Descriptor ID |
D008175
|
MeSH Number(s) |
C04.588.894.797.520 C08.381.540 C08.785.520
|
Concept/Terms |
Lung Neoplasms- Lung Neoplasms
- Pulmonary Neoplasms
- Neoplasms, Lung
- Lung Neoplasm
- Neoplasm, Lung
- Neoplasms, Pulmonary
- Neoplasm, Pulmonary
- Pulmonary Neoplasm
Lung Cancer- Lung Cancer
- Cancer, Lung
- Cancers, Lung
- Lung Cancers
- Pulmonary Cancer
- Cancer, Pulmonary
- Cancers, Pulmonary
- Pulmonary Cancers
- Cancer of the Lung
- Cancer of Lung
|
Below are MeSH descriptors whose meaning is more general than "Lung Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Lung Neoplasms".
This graph shows the total number of publications written about "Lung Neoplasms" by people in this website by year, and whether "Lung Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2002 | 2 | 1 | 3 |
2003 | 4 | 0 | 4 |
2004 | 2 | 1 | 3 |
2005 | 3 | 1 | 4 |
2006 | 3 | 2 | 5 |
2007 | 11 | 0 | 11 |
2008 | 1 | 0 | 1 |
2009 | 8 | 0 | 8 |
2010 | 8 | 2 | 10 |
2011 | 7 | 0 | 7 |
2012 | 14 | 0 | 14 |
2013 | 12 | 2 | 14 |
2014 | 15 | 0 | 15 |
2015 | 11 | 2 | 13 |
2016 | 28 | 3 | 31 |
2017 | 412 | 54 | 466 |
2018 | 384 | 45 | 429 |
2019 | 167 | 19 | 186 |
2020 | 37 | 5 | 42 |
2021 | 14 | 5 | 19 |
To return to the timeline, click here.
Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Transcriptomic studies revealed pathophysiological impact of COVID-19 to predominant health conditions. Brief Bioinform. 2021 11 05; 22(6).
-
Lenvatinib treatment for thyroid cancer in COVID era: safety in a patient with lung metastases and SARS-CoV-2 infection. Anticancer Drugs. 2021 11 01; 32(10):1116-1117.
-
Measuring the impact of the COVID-19 pandemic on organized cancer screening and diagnostic follow-up care in Ontario, Canada: A provincial, population-based study. Prev Med. 2021 10; 151:106586.
-
Repurposing Methotrexate in Dampening SARS-CoV2-S1-Mediated IL6 Expression: Lessons Learnt from Lung Cancer. Inflammation. 2022 Feb; 45(1):172-179.
-
The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells. Cancer Genomics Proteomics. 2021 Sep-Oct; 18(5):661-673.
-
S100A8 may govern hyper-inflammation in severe COVID-19. FASEB J. 2021 09; 35(9):e21798.
-
Feasibility of a novel mixed-nutrient supplement in a multimodal prehabilitation intervention for lung cancer patients awaiting surgery: A randomized controlled pilot trial. Int J Surg. 2021 Sep; 93:106079.
-
Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities. Thorac Cancer. 2021 10; 12(20):2637-2647.
-
Are COVID-19 susceptibility genes related to lung cancer? J Infect. 2021 11; 83(5):607-635.
-
[Efforts of Lung Cancer Oncologists in the"With COVID-19"Era]. Gan To Kagaku Ryoho. 2021 Aug; 48(8):1007-1011.